Rocket Pharmaceuticals (RCKT) Operating Leases (2019 - 2026)
Rocket Pharmaceuticals (RCKT) posted Operating Leases of $2.49 million for Q2 2026, down 15.0% from $2.93 million a year earlier and down 0.2% from the prior quarter.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Rocket Pharmaceuticals' Operating Leases came in at $2.6 million, down 20.2% from FY2024.
- Annual Operating Leases shows a five-year compound annual growth rate of 39.2% (FY2020 to FY2025).
- In prior years, Rocket Pharmaceuticals' Operating Leases was $3.26 million in FY2024 (+9.6%), $2.97 million in FY2023 (+173.3%), $1.09 million in FY2022 (+20.2%) and $905,000 in FY2021 (+81.7%).
- The Q2 2026 figure stands as the lowest quarterly Operating Leases since Q1 2023.
- On a year-over-year basis, Operating Leases has declined in each of the last six quarters, with an average decline of 10.6% over the last eight quarters.
- The strongest year-over-year quarter for Operating Leases in the past five years was Q3 2023, with growth of 507.7%; the weakest was Q1 2023, with a decline of 72.2%.
- According to Business Quant data, Operating Leases for the three prior quarters was $2.49 million (Q1 2026), $2.6 million (Q4 2025) and $2.76 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Rocket Pharmaceuticals | 283.71 Mn | 283.71 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.49 Mn |
| Mar 31, 2026 | 2.49 Mn |
| Dec 31, 2025 | 2.60 Mn |
| Sep 30, 2025 | 2.76 Mn |
| Jun 30, 2025 | 2.93 Mn |
| Mar 31, 2025 | 3.10 Mn |
| Dec 31, 2024 | 3.26 Mn |
| Sep 30, 2024 | 3.41 Mn |
| Jun 30, 2024 | 3.57 Mn |
| Mar 31, 2024 | 3.71 Mn |
| Dec 31, 2023 | 2.97 Mn |
| Sep 30, 2023 | 2.99 Mn |
| Jun 30, 2023 | 3.07 Mn |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 1.09 Mn |
| Sep 30, 2022 | 492,000.00 |
| Jun 30, 2022 | 606,000.00 |
| Mar 31, 2022 | 719,000.00 |
| Dec 31, 2021 | 905,000.00 |
| Sep 30, 2021 | 891,000.00 |
API Access
Rocket Pharmaceuticals Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=RCKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "RCKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=RCKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();